Lafutidine
Top View
- Protective Effects of Gastric Mucus
- Annexure-1 Patents Granted for Drugs (Products and Processes)
- A Comparative Evaluation of Lafutidine and Rabeprazole in the Treatment of Gastritis and Peptic Ulcer: a Double-Blind, Randomized Study in Indian Patients
- WO 2015/155297 Al 15 October 2015 (15.10.2015) P O P C T
- Histamine-2 Receptor Antagonists (H2RA) May Negatively Impact ADL Assessment in Patients on a Convalescent Rehabilitation Ward
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Product List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- The Pharmaceuticals and Medical Devices Agency
- Pharmaabkommen A1 E
- Lafutidine 10 Mg Versus Rabeprazole 20 Mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: a Randomized, Multicentric Trial
- PRODUCED by Pharmaqx Report For
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- (CD-P-PH/PHO) Report Classification/Justifica
- ERS Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children